Global Antibody Drug Conjugates Market By Product Type (Kadcyla, Enhertu, Adcetris, Padcev, Trodelvy, Polivy, and Others), By Technology (Type (Non-cleavable Linker, Linkerless, and Cleavable Linker), Linker Technology Type (VC, VA, Sulfo-SPDB, Hydrazone, and Others), Payload Technology (MMAF, MMAE, DM4, Camptothecin, and Others)), By Application (Blood Cancer (Multiple Myeloma, Lymphoma, and Leukemia), Breast Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Target (HER2, CD30, CD22, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Sep 2025
- Report ID: 102579
- Number of Pages: 373
- Format:
-
-
-
- Takeda Pharmaceutical Company Ltd
- Seagen, Inc
- Pfizer, Inc
- GlaxoSmithKline Plc
- Gilead Sciences, Inc
- Hoffmann-La Roche Ltd
- Daiichi Sankyo Company Ltd
- AstraZeneca Plc Company Profile
- Astellas Pharma, Inc Company Profile
- ADC Therapeutics SA
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible